Skip to content
  • Home
  • About us
  • Products
    ELISA kits
    Download catalog ELISA kits
    IMMUNOGLOBULINS LEVEL
    RAW MATERIAL
  • News
  • Contact
  • EN
  • UA
  • RU
  • Home
  • About us
  • Products
    • ELISA KITS
      • HIV infection
      • Parasites
      • Syphilis
      • Borreliosis
      • Viral Hepatitis
      • TORCH Infections
      • Herpesvirus Infections
      • Vaccine-Preventable Diseases
      • Covid-19COVID-19 is an infectious disease caused by a new SARS-CoV-2 coronavirus which had not previously been detected in humans. The viral infection leads to the development of a respiratory flu-like disease with symptoms such as cough and fever. In more severe cases pneumonia can develop. The average incubation period of the COVID-19 is 6.5 days, but it can range from 3 to 21 days. SARS-CoV-2 is an RNA-virus with a specific envelope with spikes in the form of a “corona”. The main structural proteins of the virus include envelope protein (E), membrane protein (M), spike (S) glycoprotein, and nucleocapsid (N) protein. S protein on the surface of the SARS-CoV-2 virion mediates the receptor recognition and cell membrane fusion with ACE2 molecules, which are mainly expressed on type II pneumocytes, colon and kidney epithelial cells. It contains three fragments, namely the ectodomain, the transmembrane domain and the short intracellular segment. The ectodomain consists of a receptor-binding subunit S1 containing the RBD domain and a fusion subunit (S2). During viral infection, S1 C-terminal domain binds to the extracellular peptidase (PD) domain of ACE2 to ensure that the virus attaches to the surface of the target cell. The S1 N-terminal domain binds to…
      • Urogenital Infections
      • Gastroenteric Diseases
      • Tumor Markers
      • Metabolism
      • Allergy
      • Biotinylated Allergens
      • Thyroid function
    • IMMUNOGLOBULINS LEVEL
    • RAW MATERIALS
    • DOWNLOAD CATALOG ELISA
    • DOWNLOAD CATALOG RAW MATERIALS
  • News
  • Contact
  • EN
    • EN
    • UA
    • RU
  • DOWNLOAD CATALOG ELISA
  • Home
  • About us
  • Products
    • ELISA KITS
      • HIV infection
      • Parasites
      • Syphilis
      • Borreliosis
      • Viral Hepatitis
      • TORCH Infections
      • Herpesvirus Infections
      • Vaccine-Preventable Diseases
      • Covid-19COVID-19 is an infectious disease caused by a new SARS-CoV-2 coronavirus which had not previously been detected in humans. The viral infection leads to the development of a respiratory flu-like disease with symptoms such as cough and fever. In more severe cases pneumonia can develop. The average incubation period of the COVID-19 is 6.5 days, but it can range from 3 to 21 days. SARS-CoV-2 is an RNA-virus with a specific envelope with spikes in the form of a “corona”. The main structural proteins of the virus include envelope protein (E), membrane protein (M), spike (S) glycoprotein, and nucleocapsid (N) protein. S protein on the surface of the SARS-CoV-2 virion mediates the receptor recognition and cell membrane fusion with ACE2 molecules, which are mainly expressed on type II pneumocytes, colon and kidney epithelial cells. It contains three fragments, namely the ectodomain, the transmembrane domain and the short intracellular segment. The ectodomain consists of a receptor-binding subunit S1 containing the RBD domain and a fusion subunit (S2). During viral infection, S1 C-terminal domain binds to the extracellular peptidase (PD) domain of ACE2 to ensure that the virus attaches to the surface of the target cell. The S1 N-terminal domain binds to…
      • Urogenital Infections
      • Gastroenteric Diseases
      • Tumor Markers
      • Metabolism
      • Allergy
      • Biotinylated Allergens
      • Thyroid function
    • IMMUNOGLOBULINS LEVEL
    • RAW MATERIALS
    • DOWNLOAD CATALOG ELISA
    • DOWNLOAD CATALOG RAW MATERIALS
  • News
  • Contact
  • EN
    • EN
    • UA
    • RU
  • DOWNLOAD CATALOG ELISA

Vitrotest Transglutaminase-IgA

  • Description

  • Features

  • Description

The test kit Vitrotest Transglutaminase IgA is an enzyme linked immunosorbent assay (ELISA) for the quantitative determination of IgA class antibodies to tissue transglutaminase (human tTG) in human serum or plasma.

Determination of IgA class antibodies in the test kit Vitrotest Transglutaminase IgA is based on a solid phase, indirect ELISA in a two-step incubation procedure.

  • TK156 – 96 tests

  • Features

  • Solid phase: strip ELISA plate pre-coated with recombinant human tissue transglutaminase 2.
  • Conjugate: monoclonal antibodies to human IgA conjugated with horseradish peroxidase.
  • Chromogen: ready to use TMB solution.
  • Sample volume: 10 μl.
  • Assay time: 30/30/15 min.
  • Linearity range: 7 – 164 U/ml.

Autoimmunity, ELISA KITS, TransglutaminaseIVD

tel./fax: +380972227672, +380442227672 | e-mail: info@vitrotest.ua, order@vitrotest.ua

© Vitrotest 2006 - 2026 | All Rights Reserved | Privacy policy | Terms of use

Page load link
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Attention!

You're now on our Ukrainian website.

This notice will close automatically in 7 seconds.

Go to Top